In a recent collaborative webinar hosted by the Florida Chapter of the American Academy of Pediatrics (FCAAP) and the American College of Obstetricians and Gynecologists (ACOG), expert presenters share insights into the evolving landscape of Respiratory Syncytial Virus (RSV) prevention. RSV remains one of the most significant respiratory illnesses affecting infants and young children, and recent advances offer promising strategies to mitigate its impact.
RSV is the most common cause of bronchiolitis and pneumonia in children under one year of age. Almost all children will experience an RSV infection by the age of two, but it can be particularly severe in young infants, preterm babies, and those with underlying health conditions. The U.S. experiences a marked seasonal spike in RSV cases, typically from fall through spring although the season is longer in Florida than the rest of the nation and has distinct regional patterns.
With increasing awareness of RSV’s toll, there has been a focused push toward preventive solutions for the infant as well as through the pregnant woman.
Viewers will gain a deeper understanding of RSV, prevention strategies, billing and much more. Included in the webinar are discussions on:
- The clinical presentation and burden of RSV infections in children
- RSV prevention strategies for neonates and infants
- Long term consequences and risk factors
- Epidemiology, transmission, and RSV Seasons
- Available RSV prevention products, their indications, and dosing
- Approaches to addressing vaccine hesitancy among caregivers and patients
- The role of maternal vaccination in RSV prevention
- Evaluation of product safety and efficacy data
- Billing and coding practices related to RSV immunization
View the webinar here.
Want more information to share with parents? Check out FCAAP’s public service announcement (PSA) on RSV. The PSA is currently available in English. Spanish and Haitian Creole versions are forthcoming. Watch and share today.
About the presenters:
Dr. Brandon Chatani is a board-certified pediatric infectious disease pediatrician at AdventHealth for Children. He serves as on the Chapter’s Executive Board as Secretary and is the Chair of the Chapter’s Immunization Committee.
Dr. Tina O’Shea is an assistant professor at the University of Florida Department of Obstetrics and Gynecology. She serves as a representative of ACOG District 12 and is a committee member of District 12’s Committee on Healthcare for Underserved Women.
